CA2060208A1 - Traitement des plaies - Google Patents

Traitement des plaies

Info

Publication number
CA2060208A1
CA2060208A1 CA2060208A CA2060208A CA2060208A1 CA 2060208 A1 CA2060208 A1 CA 2060208A1 CA 2060208 A CA2060208 A CA 2060208A CA 2060208 A CA2060208 A CA 2060208A CA 2060208 A1 CA2060208 A1 CA 2060208A1
Authority
CA
Canada
Prior art keywords
wound healing
mammal
growth factor
healing
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2060208A
Other languages
English (en)
Other versions
CA2060208C (fr
Inventor
Harry N. Antoniades
Samuel E. Lynch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomimetic Therapeutics LLC
Harvard University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2060208A1 publication Critical patent/CA2060208A1/fr
Application granted granted Critical
Publication of CA2060208C publication Critical patent/CA2060208C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Electronic Switches (AREA)
CA002060208A 1990-04-10 1990-04-10 Traitement des plaies Expired - Lifetime CA2060208C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1990/001936 WO1991015231A1 (fr) 1990-04-10 1990-04-10 Cicatrisation de plaies

Publications (2)

Publication Number Publication Date
CA2060208A1 true CA2060208A1 (fr) 1991-10-11
CA2060208C CA2060208C (fr) 2001-02-20

Family

ID=22220789

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002060208A Expired - Lifetime CA2060208C (fr) 1990-04-10 1990-04-10 Traitement des plaies

Country Status (8)

Country Link
EP (1) EP0479799B1 (fr)
JP (1) JPH0768139B2 (fr)
AT (1) ATE156363T1 (fr)
CA (1) CA2060208C (fr)
DE (1) DE69031218T2 (fr)
DK (1) DK0479799T3 (fr)
ES (1) ES2106031T3 (fr)
WO (1) WO1991015231A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69725881T2 (de) 1996-12-13 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Verfahren zur expression von heterologen proteinen in hefe
RU2149644C1 (ru) * 1997-11-28 2000-05-27 Открытое акционерное общество "СПб-Технология" Способ лечения заболеваний, сопровождающихся образованием гноя и/или некротических тканей
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
AUPR774201A0 (en) 2001-09-18 2001-10-11 U.S. Filter Wastewater Group, Inc. High solids module
US7247238B2 (en) 2002-02-12 2007-07-24 Siemens Water Technologies Corp. Poly(ethylene chlorotrifluoroethylene) membranes
AU2005240524C1 (en) 2004-04-22 2009-12-24 Evoqua Water Technologies Llc Filtration apparatus comprising a membrane bioreactor and a treatment vessel for digesting organic materials
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US8114841B2 (en) 2004-10-14 2012-02-14 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix
US7591950B2 (en) 2004-11-02 2009-09-22 Siemens Water Technologies Corp. Submerged cross-flow filtration
SG140229A1 (en) 2005-08-22 2008-03-28 Siemens Water Tech Corp An assembly for water filtration using a tube manifold to minimise backwash
WO2007044345A2 (fr) 2005-10-05 2007-04-19 Siemens Water Technologies Corp. Procede et appareil permettant de traiter des eaux usees
US7455765B2 (en) 2006-01-25 2008-11-25 Siemens Water Technologies Corp. Wastewater treatment system and method
ES2427993T3 (es) 2006-02-09 2013-11-05 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
CA2656278C (fr) 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions et procedes destines au traitement de lesions de la coiffe des rotateurs
US8106008B2 (en) 2006-11-03 2012-01-31 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
EP2259807B1 (fr) 2008-02-07 2013-04-24 Biomimetic Therapeutics, Inc. Compositions associés à une ostéogenèse par distraction
KR20110067035A (ko) 2008-09-09 2011-06-20 바이오미메틱 세라퓨틱스, 인크. 건 및 인대 손상의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법
CN102811622A (zh) 2010-02-22 2012-12-05 生物模拟治疗公司 用于治疗腱病的血小板衍生生长因子组合物和方法
MX2017004520A (es) 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322714C (fr) * 1986-11-14 1993-10-05 Harry N. Antoniades Cicatrisation et regeneration osseuse
IE60517B1 (en) * 1986-11-14 1994-07-27 Inst Molecular Biology Inc Wound healing and bone regeneration
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing

Also Published As

Publication number Publication date
JPH0768139B2 (ja) 1995-07-26
EP0479799A4 (en) 1993-03-31
ES2106031T3 (es) 1997-11-01
ATE156363T1 (de) 1997-08-15
DK0479799T3 (da) 1997-08-25
EP0479799B1 (fr) 1997-08-06
CA2060208C (fr) 2001-02-20
WO1991015231A1 (fr) 1991-10-17
JPH05500356A (ja) 1993-01-28
DE69031218T2 (de) 1997-12-11
DE69031218D1 (de) 1997-09-11
EP0479799A1 (fr) 1992-04-15

Similar Documents

Publication Publication Date Title
CA2060208A1 (fr) Traitement des plaies
OA09159A (en) Wound healing and bone regeneration.
CA2040410A1 (fr) Compositions pour traiter des plaies contenant de l'interleukine 1 et un facteur de croissance
ATE109352T1 (de) Heilung von wunden.
AU642784B2 (en) External dermatological composition
IL89166A0 (en) Pharmaceutical compositions comprising insulin-like growth factor i
AU4319789A (en) Wound healing
CS141387A2 (en) Microbicide
GB9206492D0 (en) Wound healing composition
AU4302993A (en) 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxy lic acid compounds and related compounds as antibacterial agents
AU6168190A (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
AU1271592A (en) Malic acid derivatives and compositions for the treatment of psoriasis
CA2011452A1 (fr) Compose pharmaceutique contenant un vecteur acceptable en pharmacologie et un compose de (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-19-pregn-5-(10)-en-20-yn- 3-one
EP0221728A3 (en) Monosaccharide containing wound healing preparation
CA2058597A1 (fr) Compositions cicatrisantes a base de facteur de croissance de fibroblaste et d'acide ascorbique
AU4553089A (en) Fabric treatment composition
CA2082420A1 (fr) Composition cicatrisante comprenant du igf-i ou igf-ii purifie et un tgf-.beta. purifie
AU610175B2 (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
AU3182893A (en) Topical composition for accelerating wound healing
AU7508594A (en) Medical use of polysulfonic acid compound
AU4102789A (en) Treatment compositions
AU2403592A (en) 2-aza-2-desamino analogues of 5,8-dideazafolic acid
AU8282987A (en) Composition for defoliation of plants i
AU1845992A (en) Use of 9, 12, 15-octadecatriene-6-ynoic acid
CA2367124A1 (fr) Fraction thrombine du sang pour utilisation dans une procedure medicale

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry